Simultaneous measurement of plasma vitamin D(3) metabolites, including 4β,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry.

Simultaneous and accurate measurement of circulating vitamin D metabolites is critical to studies of the metabolic regulation of vitamin D and its impact on health and disease. To that end, we have developed a specific liquid chromatography-tandem mass spectrometry (LC-MS/MS) method that permits the quantification of major circulating vitamin D(3) metabolites in human plasma. Plasma samples were subjected to a protein precipitation, liquid-liquid extraction, and Diels-Alder derivatization procedure prior to LC-MS/MS analysis. Importantly, in all human plasma samples tested, we identified a significant dihydroxyvitamin D(3) peak that could potentially interfere with the determination of 1α,25-dihydroxyvitamin D(3) [1α,25(OH)(2)D(3)] concentrations. This interfering metabolite has been identified as 4β,25-dihydroxyvitamin D(3) [4β,25(OH)(2)D(3)] and was found at concentrations comparable to 1α,25(OH)(2)D(3). Quantification of 1α,25(OH)(2)D(3) in plasma required complete chromatographic separation of 1α,25(OH)(2)D(3) from 4β,25(OH)(2)D(3). An assay incorporating this feature was used to simultaneously determine the plasma concentrations of 25OHD(3), 24R,25(OH)(2)D(3), 1α,25(OH)(2)D(3), and 4β,25(OH)(2)D(3) in healthy individuals. The LC-MS/MS method developed and described here could result in considerable improvement in quantifying 1α,25(OH)(2)D(3) as well as monitoring the newly identified circulating metabolite, 4β,25(OH)(2)D(3).

[1]  M. Ashwell,et al.  UK Food Standards Agency Workshop Consensus Report: the choice of method for measuring 25-hydroxyvitamin D to estimate vitamin D status for the UK National Diet and Nutrition Survey. , 2010, The British journal of nutrition.

[2]  A. Norman,et al.  Vitamin D: metabolism and biological actions. , 1984, Annual review of nutrition.

[3]  M. Vogeser.  Quantification of circulating 25-hydroxyvitamin D by liquid chromatography–tandem mass spectrometry , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  B. Casetta,et al.  Development of a Method for the Quantification of 1α,25(OH)2–Vitamin D3 in Serum by Liquid Chromatography Tandem Mass Spectrometry without Derivatization , 2010, European journal of mass spectrometry.

[5]  M. Kozak,et al.  Sensitive measurement of serum 1α,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction. , 2011, Rapid communications in mass spectrometry : RCM.

[6]  Leimin Fan,et al.  Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS. , 2007, Journal of pharmaceutical and biomedical analysis.

[7]  K. Phinney,et al.  Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. , 2010, Analytical chemistry.

[8]  M. Shimizu,et al.  Isolation and identification of 2α,25-dihydroxyvitamin D3, a new metabolite from Pseudonocardia autotrophica 100U-19 cells incubated with Vitamin D3 , 2006, Steroids.

[9]  B. Hammock,et al.  Metabolic profiling of major vitamin D metabolites using Diels–Alder derivatization and ultra-performance liquid chromatography–tandem mass spectrometry , 2008, Analytical and bioanalytical chemistry.

[10]  M. Holick,et al.  Vitamin D status: measurement, interpretation, and clinical application. , 2009, Annals of epidemiology.

[11]  H. Weber,et al.  Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography–tandem mass spectrometry as a reference , 2008, Annals of clinical biochemistry.

[12]  B. Hollis,et al.  The assessment of circulating 25(OH)D and 1,25(OH)2D: Where we are and where we are going , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  A. Prentice,et al.  Vitamin D across the lifecycle: physiology and biomarkers. , 2008, The American journal of clinical nutrition.

[14]  J. Mora,et al.  Vitamin effects on the immune system: vitamins A and D take centre stage , 2008, Nature Reviews Immunology.

[15]  J. M. van den Ouweland,et al.  Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  J. C. Hamilton.  A rapid simplified method for plasma 25-hydroxyvitamin D estimation. , 1980, Journal of clinical pathology.

[17]  J. Haddad,et al.  COMPETITIVE PROTEIN-BINDING RADIOASSAY FOR 25-HYDROXYCHOLECALCIFEROL1 , 1971 .

[18]  A. Prentice,et al.  Quantitative determination of vitamin D metabolites in plasma using UHPLC-MS/MS , 2010, Analytical and bioanalytical chemistry.

[19]  T. Higashi,et al.  Simultaneous determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma by liquid chromatography-tandem mass spectrometry employing derivatization with a Cookson-type reagent. , 2001, Biological & pharmaceutical bulletin.

[20]  K. Bodin,et al.  Metabolism of 25-hydroxyvitamin D3 by microsomal and mitochondrial vitamin D3 25-hydroxylases (CYP2D25 and CYP27A1): a novel reaction by CYP27A1. , 2003, Biochimica et biophysica acta.

[21]  G. Carter,et al.  The anomalous behaviour of exogenous 25-hydroxyvitamin D in competitive binding assays , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  G. Jones.  Assay of vitamins D2 and D3, and 25-hydroxyvitamins D2 and D3 in human plasma by high-performance liquid chromatography. , 1978, Clinical chemistry.

[23]  Y. Ohyama,et al.  Eight cytochrome P450s catalyze vitamin D metabolism. , 2004, Frontiers in bioscience : a journal and virtual library.

[24]  Tatsuya Higashi,et al.  Advances in determination of vitamin D related compounds in biological samples using liquid chromatography-mass spectrometry: a review. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[25]  H. Pols,et al.  Vitamin D , 1928, Calcified Tissue International.

[26]  T. Higashi,et al.  Application of 4-(4-Nitrophenyl)-1,2,4-triazoline-3,5-dione to Analysis of 25- Hydroxyvitamin D3 in Human Plasma by Liquid Chromatography/Electron Capture Atmospheric Pressure Chemical Ionization-Mass Spectrometry , 2003, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[27]  H. DeLuca,et al.  Current understanding of the molecular actions of vitamin D. , 1998, Physiological reviews.

[28]  H. DeLuca,et al.  Vitamin D, disease and therapeutic opportunities , 2010, Nature Reviews Drug Discovery.

[29]  D. Naughton,et al.  Vitamin D in health and disease: Current perspectives , 2010, Nutrition journal.

[30]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[31]  Sihe Wang,et al.  Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues. , 2011, Clinical biochemistry.

[32]  B. Hollis,et al.  Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. , 1993, Clinical chemistry.

[33]  A. Wallace,et al.  A simple automated solid-phase extraction procedure for measurement of 25-hydroxyvitamin D3 and D2 by liquid chromatography-tandem mass spectrometry , 2009, Annals of clinical biochemistry.

[34]  Katharina Olszewski,et al.  Rapid determination of 25-hydroxy vitamin D3 in swine tissue using an isotope dilution HPLC-MS assay. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[35]  S. Durham,et al.  Measurement of vitamin D status: background, clinical use, and methodologies. , 2006, Clinical laboratory.

[36]  A. Kissmeyer,et al.  Sensitive analysis of 1α,25-dihydroxyvitamin D3 in biological fluids by liquid chromatography–tandem mass spectrometry , 2001 .

[37]  M. Seibel,et al.  A new quantitative LC tandem mass spectrometry assay for serum 25-hydroxy vitamin D , 2010, Steroids.

[38]  P. Glendenning,et al.  Issues of methodology, standardization and metabolite recognition for 25-hydroxyvitamin D when comparing the DiaSorin radioimmunoassay and the Nichols Advantage automated chemiluminescence protein-binding assay in hip fracture cases , 2003, Annals of clinical biochemistry.

[39]  Tatsuya Higashi,et al.  Derivatization of neutral steroids to enhance their detection characteristics in liquid chromatography–mass spectrometry , 2004, Analytical and bioanalytical chemistry.

[40]  H. DeLuca.  The vitamin D story: a collaborative effort of basic science and clinical medicine 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  T. Higashi,et al.  Gas chromatography and high-performance liquid chromatography of natural steroids. , 2001, Journal of chromatography. A.

[42]  Glenville Jones,et al.  Enzymes involved in the activation and inactivation of vitamin D. , 2004, Trends in biochemical sciences.

[43]  J. L. Napoli,et al.  Ring hydroxylation of 25-hydroxycholecalciferol by rat renal microsomes. , 1988, Journal of steroid biochemistry.

[44]  M. Ashwell,et al.  Measurement of 25-hydroxyvitamin D in the clinical laboratory: Current procedures, performance characteristics and limitations , 2010, Steroids.

[45]  M. Holick.  Vitamin D and sunlight: strategies for cancer prevention and other health benefits. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[46]  David Hall,et al.  Issues in Methodology , 1996 .

[47]  M. Ramanathan,et al.  Ultrasensitive quantification of serum vitamin D metabolites using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry. , 2010, Analytical chemistry.